Article Text

Download PDFPDF
Utilisation of a cryptic non-canonical donor splice site of the gene encoding PARAFIBROMIN is associated with familial isolated primary hyperparathyroidism
  1. K J Bradley1,*,
  2. B M Cavaco1,2,*,
  3. M R Bowl1,
  4. B Harding1,
  5. A Young3,
  6. R V Thakker1
  1. 1Academic Endocrine Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), Churchill Hospital, Headington, Oxford OX3 7LJ, UK
  2. 2Centro de Investigação de Patobiologia Molecular, Instituto Português de Oncologia de Francisco Gentil, C.R.O.L., S.A., Rua Professor Lima Basto, 1099-023 Lisbon, Portugal
  3. 3Department of Surgery, St Thomas’ Hospital, London, UK
  1. Correspondence to:
 Professor R V Thakker
 Academic Endocrine Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), Churchill Hospital, Headington, Oxford OX3 7LJ, UK; rajesh.thakkerndm.ox.ac.uk

Abstract

More than 99% of all splice sites conform to consensus sequences that usually include the invariant dinucleotides gt and ag at the 5′ and 3′ ends of the introns, respectively. We report on the utilisation of a non-consensus (non-canonical) donor splice site within exon 1 of the HRPT2 gene in familial isolated primary hyperparathyroidism (FIHP). HRPT2 mutations are more frequently associated with the hyperparathyroidism-jaw tumour syndrome (HPT-JT). Patients with FIHP were identified to have a donor splice site mutation, IVS1+1 g→a, and the consequences of this for RNA processing were investigated. The mutant mRNA lacked 30 bp and DNA sequence analysis revealed this to result from utilisation of an alternative cryptic non-canonical donor splice site (gaatgt) in exon 1 together with the normally occurring acceptor splice site in intron 1. Translation of this mutant mRNA predicted the in-frame loss of 10 amino acids in the encoded protein, termed PARAFIBROMIN. Thus, these FIHP patients are utilising a ga-ag splice site pair, which until recently was considered to be incompatible with splicing but is now known to occur as a rare (<0.02%) normal splicing variant.

  • ARMS, amplification refractory mutation system
  • EBV, Epstein-Barr virus
  • FIHP, familial isolated primary hyperparathyroidism
  • HPT, hyperparathyroidism
  • HPT-JT, hyperparathyroidism-jaw tumour syndrome
  • m, mutant
  • MEN, multiple endocrine neoplasia
  • PTH, parathyroid hormone
  • RT-PCR, reverse transcriptase PCR
  • SpaGVs, splicing affecting genomic variants
  • WT, wild type
  • chromosome 1q
  • genomic variants
  • hyperparathyroidism-jaw tumour syndrome
  • splicing
  • tumour suppressor

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • * These authors contributed equally to this work

  • We are grateful for support to the Medical Research Council, United Kingdom (KJB, MRB, BH, RVT) and to Fundação Calouste Gulbenkian, Lisbon, Portugal (BMC). KJB is an MRC Clinical Training Fellow.

  • Competing interests: none declared